

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.05143516 |
| 2 | regulation of regulatory T cell differentiation (GO:0045589) | 5.75495876 |
| 3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.71605889 |
| 4 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.40192244 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 5.18511867 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.73182220 |
| 7 | positive regulation of humoral immune response (GO:0002922) | 4.49061843 |
| 8 | negative regulation of protein oligomerization (GO:0032460) | 4.34549127 |
| 9 | positive regulation of CREB transcription factor activity (GO:0032793) | 4.30846420 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.97341531 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95272242 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.90773588 |
| 13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85206073 |
| 14 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.85004451 |
| 15 | myeloid dendritic cell activation (GO:0001773) | 3.83959685 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.82103084 |
| 17 | regulation of protein homooligomerization (GO:0032462) | 3.79875735 |
| 18 | T cell homeostasis (GO:0043029) | 3.77049390 |
| 19 | neurotransmitter secretion (GO:0007269) | 3.72938720 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.68443308 |
| 21 | pericardium development (GO:0060039) | 3.64158744 |
| 22 | glutamate secretion (GO:0014047) | 3.62833326 |
| 23 | protein localization to cilium (GO:0061512) | 3.61936281 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.61763069 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61763069 |
| 26 | myeloid dendritic cell differentiation (GO:0043011) | 3.49584701 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.48887148 |
| 28 | coronary vasculature morphogenesis (GO:0060977) | 3.47285675 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.44484799 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42854972 |
| 31 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.41263858 |
| 32 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.39344187 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 3.33305186 |
| 34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.31883452 |
| 35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30357414 |
| 36 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.29801470 |
| 37 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.27464992 |
| 38 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.27464992 |
| 39 | response to type I interferon (GO:0034340) | 3.24991434 |
| 40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.24591821 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.22141575 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.22141575 |
| 43 | cellular extravasation (GO:0045123) | 3.21873309 |
| 44 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.21809827 |
| 45 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.21809827 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20181839 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 3.18571393 |
| 48 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.17468417 |
| 49 | positive regulation of B cell mediated immunity (GO:0002714) | 3.17468417 |
| 50 | proline transport (GO:0015824) | 3.17325603 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11610897 |
| 52 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.11037378 |
| 53 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.11037378 |
| 54 | positive regulation of Rap GTPase activity (GO:0032854) | 3.09266187 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09100662 |
| 56 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.08970325 |
| 57 | histone H3-K4 trimethylation (GO:0080182) | 3.08252748 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.08205095 |
| 59 | defense response to protozoan (GO:0042832) | 3.06092684 |
| 60 | axon ensheathment in central nervous system (GO:0032291) | 3.05601143 |
| 61 | central nervous system myelination (GO:0022010) | 3.05601143 |
| 62 | regulation of hypersensitivity (GO:0002883) | 3.05227527 |
| 63 | response to protozoan (GO:0001562) | 3.04901931 |
| 64 | negative regulation of cell killing (GO:0031342) | 3.03103753 |
| 65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03103753 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02722732 |
| 67 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00825973 |
| 68 | cerebellar granule cell differentiation (GO:0021707) | 3.00069001 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 2.97916347 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 2.95115017 |
| 71 | synaptic transmission, glutamatergic (GO:0035249) | 2.94474787 |
| 72 | neurotransmitter transport (GO:0006836) | 2.94409182 |
| 73 | membrane depolarization during action potential (GO:0086010) | 2.91250639 |
| 74 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91142200 |
| 75 | toxin transport (GO:1901998) | 2.86514446 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 2.85933995 |
| 77 | regulation of ARF protein signal transduction (GO:0032012) | 2.85924581 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 2.85904680 |
| 79 | positive regulation of membrane potential (GO:0045838) | 2.85480976 |
| 80 | respiratory burst (GO:0045730) | 2.85438481 |
| 81 | lipopolysaccharide metabolic process (GO:0008653) | 2.84124750 |
| 82 | potassium ion import (GO:0010107) | 2.81978737 |
| 83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78682682 |
| 84 | cellular response to zinc ion (GO:0071294) | 2.78033552 |
| 85 | regulation of synaptic vesicle transport (GO:1902803) | 2.77179205 |
| 86 | neuron-neuron synaptic transmission (GO:0007270) | 2.76017808 |
| 87 | mast cell activation (GO:0045576) | 2.75209662 |
| 88 | negative regulation of lipid catabolic process (GO:0050995) | 2.75136989 |
| 89 | neuronal action potential propagation (GO:0019227) | 2.73582713 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72441188 |
| 91 | positive regulation of dendritic spine development (GO:0060999) | 2.69811440 |
| 92 | potassium ion homeostasis (GO:0055075) | 2.69369640 |
| 93 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.68524588 |
| 94 | regulation of Rap GTPase activity (GO:0032317) | 2.68220744 |
| 95 | leukocyte aggregation (GO:0070486) | 2.66840601 |
| 96 | negative regulation of phagocytosis (GO:0050765) | 2.66653266 |
| 97 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.66206818 |
| 98 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.65112857 |
| 99 | calcium ion-dependent exocytosis (GO:0017156) | 2.63768283 |
| 100 | glutamate receptor signaling pathway (GO:0007215) | 2.62815529 |
| 101 | negative T cell selection (GO:0043383) | 2.62755269 |
| 102 | regulation of ARF GTPase activity (GO:0032312) | 2.62368565 |
| 103 | lymphocyte homeostasis (GO:0002260) | 2.62255662 |
| 104 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60925933 |
| 105 | regulation of synapse maturation (GO:0090128) | 2.60713224 |
| 106 | interferon-gamma production (GO:0032609) | 2.59231481 |
| 107 | positive regulation of histone deacetylation (GO:0031065) | 2.58972897 |
| 108 | regulation of protein homodimerization activity (GO:0043496) | 2.58089093 |
| 109 | megakaryocyte development (GO:0035855) | 2.56623238 |
| 110 | negative thymic T cell selection (GO:0045060) | 2.56393217 |
| 111 | auditory receptor cell differentiation (GO:0042491) | 2.55334427 |
| 112 | natural killer cell activation involved in immune response (GO:0002323) | 2.55304568 |
| 113 | definitive hemopoiesis (GO:0060216) | 2.54817723 |
| 114 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.51642915 |
| 115 | activated T cell proliferation (GO:0050798) | 2.51564808 |
| 116 | nephron tubule morphogenesis (GO:0072078) | 2.51286393 |
| 117 | nephron epithelium morphogenesis (GO:0072088) | 2.51286393 |
| 118 | establishment of protein localization to Golgi (GO:0072600) | 2.50377605 |
| 119 | brain morphogenesis (GO:0048854) | 2.49330564 |
| 120 | axoneme assembly (GO:0035082) | 2.49178033 |
| 121 | nerve growth factor signaling pathway (GO:0038180) | 2.48900617 |
| 122 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.48374490 |
| 123 | detection of light stimulus involved in visual perception (GO:0050908) | 2.48366459 |
| 124 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.48366459 |
| 125 | cell differentiation in hindbrain (GO:0021533) | 2.47943574 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 2.47714946 |
| 127 | T cell lineage commitment (GO:0002360) | 2.47098193 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.46855715 |
| 129 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.46518409 |
| 130 | regulation of RNA export from nucleus (GO:0046831) | 2.46132074 |
| 131 | ketone body metabolic process (GO:1902224) | 2.45880746 |
| 132 | alanine transport (GO:0032328) | 2.45432739 |
| 133 | chemosensory behavior (GO:0007635) | 2.44472914 |
| 134 | positive regulation of isotype switching (GO:0045830) | 2.44354330 |
| 135 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.44204747 |
| 136 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.43287765 |
| 137 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.42915198 |
| 138 | positive regulation of granulocyte differentiation (GO:0030854) | 2.42657605 |
| 139 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.42624555 |
| 140 | actin filament polymerization (GO:0030041) | 2.42579703 |
| 141 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.42109106 |
| 142 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.41966118 |
| 143 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.40790390 |
| 144 | positive regulation of DNA recombination (GO:0045911) | 2.40457587 |
| 145 | negative regulation of monooxygenase activity (GO:0032769) | 2.40383579 |
| 146 | neuromuscular synaptic transmission (GO:0007274) | 2.40359803 |
| 147 | regulation of RIG-I signaling pathway (GO:0039535) | 2.40163381 |
| 148 | response to pheromone (GO:0019236) | 2.39467491 |
| 149 | dendritic cell differentiation (GO:0097028) | 2.39199987 |
| 150 | phospholipid dephosphorylation (GO:0046839) | 2.39129665 |
| 151 | urinary tract smooth muscle contraction (GO:0014848) | 2.38780855 |
| 152 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.38749612 |
| 153 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.38476635 |
| 154 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.38292604 |
| 155 | leukocyte homeostasis (GO:0001776) | 2.37691219 |
| 156 | regulation of B cell mediated immunity (GO:0002712) | 2.37586677 |
| 157 | detection of calcium ion (GO:0005513) | 2.37258059 |
| 158 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.36872675 |
| 159 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.36831927 |
| 160 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.36156492 |
| 161 | histone H3-K9 demethylation (GO:0033169) | 2.35929548 |
| 162 | dendritic spine morphogenesis (GO:0060997) | 2.35379891 |
| 163 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.34063005 |
| 164 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.33620719 |
| 165 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.33421896 |
| 166 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33210549 |
| 167 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.33000284 |
| 168 | regulation of neurotransmitter secretion (GO:0046928) | 2.32723749 |
| 169 | glomerular filtration (GO:0003094) | 2.32516498 |
| 170 | protein targeting to Golgi (GO:0000042) | 2.32385195 |
| 171 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.32355151 |
| 172 | macroautophagy (GO:0016236) | 2.32222382 |
| 173 | response to interleukin-15 (GO:0070672) | 2.32197318 |
| 174 | adult walking behavior (GO:0007628) | 2.31455728 |
| 175 | regulation of synapse structural plasticity (GO:0051823) | 2.30157152 |
| 176 | cellular potassium ion transport (GO:0071804) | 2.28056686 |
| 177 | potassium ion transmembrane transport (GO:0071805) | 2.28056686 |
| 178 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.27871399 |
| 179 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.27503890 |
| 180 | RNA destabilization (GO:0050779) | 2.27051247 |
| 181 | positive regulation of Rab GTPase activity (GO:0032851) | 2.26464648 |
| 182 | regulation of Rab GTPase activity (GO:0032313) | 2.26464648 |
| 183 | negative regulation of gluconeogenesis (GO:0045721) | 2.26321125 |
| 184 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.25409930 |
| 185 | inositol phosphate catabolic process (GO:0071545) | 2.25085094 |
| 186 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.24929553 |
| 187 | L-amino acid import (GO:0043092) | 2.24105210 |
| 188 | startle response (GO:0001964) | 2.23410454 |
| 189 | sperm motility (GO:0030317) | 2.23262773 |
| 190 | phosphatidylinositol phosphorylation (GO:0046854) | 2.22771240 |
| 191 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.22597696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.26989159 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.98602612 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.41168013 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38895994 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27485922 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08155265 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02936085 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.61907488 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35905495 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30916914 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30569007 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20370138 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18529744 |
| 14 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15222308 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13864999 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.13541027 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12969449 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.08748808 |
| 19 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06340287 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97724084 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96912030 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92185715 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89197925 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.86182497 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82908659 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78960922 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77808982 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77067697 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76509424 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73664427 |
| 31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72922707 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72307667 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70236166 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69521581 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66972049 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63932212 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60162103 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.58728055 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55740518 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.55166907 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53682356 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52916505 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.52411798 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.49576430 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41604374 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40333605 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39923315 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36607633 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35547562 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32981215 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31047310 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.30854609 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.28470532 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28368266 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28267680 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26713727 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25206835 |
| 58 | * MYB_26560356_Chip-Seq_TH1_Human | 1.24980423 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24791282 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.24480003 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24238688 |
| 62 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23955020 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23814119 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23623278 |
| 65 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22810472 |
| 66 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.22632097 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21478817 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20711795 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.20086941 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20064126 |
| 71 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19268504 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.19157768 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18663965 |
| 74 | * MAF_26560356_Chip-Seq_TH2_Human | 1.18531298 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18517990 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18447467 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15014464 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14413551 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.13338589 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.12643138 |
| 81 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11182733 |
| 82 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11182733 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10796011 |
| 84 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.10101468 |
| 85 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09672196 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09210009 |
| 87 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08859767 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08739897 |
| 89 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08633333 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07509280 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06164290 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05597961 |
| 93 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.05487852 |
| 94 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05469234 |
| 95 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05469234 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05202232 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04436592 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02871947 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01376115 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01369148 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01006413 |
| 102 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00798883 |
| 103 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00380685 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99829444 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98958498 |
| 106 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.97437999 |
| 107 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.97007576 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96913599 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96907417 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96518747 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96518254 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96498118 |
| 113 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.94742945 |
| 114 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94667990 |
| 115 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.94132331 |
| 116 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.94056889 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93677055 |
| 118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93399087 |
| 119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93009915 |
| 120 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92802533 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91057701 |
| 122 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.90854507 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90329915 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89804361 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88651189 |
| 126 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88442008 |
| 127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87672580 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86669358 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86585497 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86545280 |
| 131 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86511982 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86464920 |
| 133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86416278 |
| 134 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86185221 |
| 135 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86083306 |
| 136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85965176 |
| 137 | AR_19668381_ChIP-Seq_PC3_Human | 0.85560084 |
| 138 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.84474628 |
| 139 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.83828012 |
| 140 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.83778362 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82968976 |
| 142 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82695482 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82164320 |
| 144 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.82084415 |
| 145 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82036429 |
| 146 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81831082 |
| 147 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80818315 |
| 148 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80339257 |
| 149 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79717515 |
| 150 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78910801 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78753326 |
| 152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78196810 |
| 153 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.77128560 |
| 154 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77096381 |
| 155 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.74552263 |
| 156 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.71696886 |
| 157 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71085752 |
| 158 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70689982 |
| 159 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.69657217 |
| 160 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.69291105 |
| 161 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.68714809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.17742846 |
| 2 | MP0003787_abnormal_imprinting | 2.73260024 |
| 3 | MP0005671_abnormal_response_to | 2.72275472 |
| 4 | MP0003122_maternal_imprinting | 2.59409346 |
| 5 | MP0003436_decreased_susceptibility_to | 2.53439197 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.52278307 |
| 7 | MP0002064_seizures | 2.49213874 |
| 8 | MP0003880_abnormal_central_pattern | 2.44375987 |
| 9 | MP0003303_peritoneal_inflammation | 2.38456772 |
| 10 | MP0003866_abnormal_defecation | 2.36449717 |
| 11 | MP0002822_catalepsy | 2.33421731 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.33377349 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.30882581 |
| 14 | MP0009745_abnormal_behavioral_response | 2.30716451 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.23563392 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.23349683 |
| 17 | MP0003879_abnormal_hair_cell | 2.23275652 |
| 18 | MP0002272_abnormal_nervous_system | 2.18456271 |
| 19 | MP0009046_muscle_twitch | 2.10363660 |
| 20 | MP0005670_abnormal_white_adipose | 2.07991970 |
| 21 | MP0004142_abnormal_muscle_tone | 2.03858960 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.03696133 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.92715221 |
| 24 | MP0004885_abnormal_endolymph | 1.91599942 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.89587114 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.87889572 |
| 27 | MP0001790_abnormal_immune_system | 1.86584752 |
| 28 | MP0005387_immune_system_phenotype | 1.86584752 |
| 29 | MP0002419_abnormal_innate_immunity | 1.85954962 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.82862431 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.79990292 |
| 32 | MP0008569_lethality_at_weaning | 1.78173346 |
| 33 | MP0005360_urolithiasis | 1.71482113 |
| 34 | MP0004742_abnormal_vestibular_system | 1.69078920 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 1.67563287 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.67241702 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.64901212 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.64285602 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.63748754 |
| 40 | MP0001800_abnormal_humoral_immune | 1.63572679 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.62398456 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.61887608 |
| 43 | MP0003195_calcinosis | 1.61028538 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.60589267 |
| 45 | MP0002723_abnormal_immune_serum | 1.59944079 |
| 46 | MP0001819_abnormal_immune_cell | 1.59028798 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.58943222 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.58598882 |
| 49 | MP0005025_abnormal_response_to | 1.56742680 |
| 50 | MP0001970_abnormal_pain_threshold | 1.55128497 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.54535221 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.54117004 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.54041164 |
| 54 | MP0003943_abnormal_hepatobiliary_system | 1.53427890 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.53007629 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.51037096 |
| 57 | MP0004147_increased_porphyrin_level | 1.50575213 |
| 58 | MP0004043_abnormal_pH_regulation | 1.50493834 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.49577026 |
| 60 | MP0002398_abnormal_bone_marrow | 1.49486871 |
| 61 | MP0001873_stomach_inflammation | 1.49139693 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.47309378 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.47309378 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.46626594 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.45827818 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.43739772 |
| 67 | MP0005410_abnormal_fertilization | 1.43587305 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.42824698 |
| 69 | MP0003633_abnormal_nervous_system | 1.41155471 |
| 70 | MP0003136_yellow_coat_color | 1.40496732 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.39604951 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.39019522 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.38946366 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.38678600 |
| 75 | MP0002229_neurodegeneration | 1.34579865 |
| 76 | MP0000716_abnormal_immune_system | 1.34208242 |
| 77 | MP0002928_abnormal_bile_duct | 1.33226427 |
| 78 | MP0005535_abnormal_body_temperature | 1.31345237 |
| 79 | MP0005058_abnormal_lysosome_morphology | 1.30905579 |
| 80 | MP0002405_respiratory_system_inflammati | 1.29987806 |
| 81 | MP0003121_genomic_imprinting | 1.29795779 |
| 82 | MP0001188_hyperpigmentation | 1.29750115 |
| 83 | MP0002557_abnormal_social/conspecific_i | 1.27591717 |
| 84 | MP0002693_abnormal_pancreas_physiology | 1.26932349 |
| 85 | MP0005409_darkened_coat_color | 1.25530280 |
| 86 | MP0000490_abnormal_crypts_of | 1.24677845 |
| 87 | MP0000685_abnormal_immune_system | 1.24238004 |
| 88 | MP0003123_paternal_imprinting | 1.23339217 |
| 89 | MP0000703_abnormal_thymus_morphology | 1.23064297 |
| 90 | MP0002876_abnormal_thyroid_physiology | 1.21462728 |
| 91 | MP0003724_increased_susceptibility_to | 1.21054244 |
| 92 | MP0002006_tumorigenesis | 1.20728764 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 1.19826870 |
| 94 | MP0004924_abnormal_behavior | 1.17010277 |
| 95 | MP0005386_behavior/neurological_phenoty | 1.17010277 |
| 96 | MP0003631_nervous_system_phenotype | 1.14898157 |
| 97 | MP0004270_analgesia | 1.13386007 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 1.11847102 |
| 99 | MP0009785_altered_susceptibility_to | 1.11560911 |
| 100 | MP0010329_abnormal_lipoprotein_level | 1.11047289 |
| 101 | MP0001765_abnormal_ion_homeostasis | 1.10492009 |
| 102 | MP0002722_abnormal_immune_system | 1.09903773 |
| 103 | MP0003635_abnormal_synaptic_transmissio | 1.08417428 |
| 104 | MP0000013_abnormal_adipose_tissue | 1.07953667 |
| 105 | MP0002429_abnormal_blood_cell | 1.07873652 |
| 106 | MP0004811_abnormal_neuron_physiology | 1.07804339 |
| 107 | MP0006082_CNS_inflammation | 1.07596788 |
| 108 | MP0004381_abnormal_hair_follicle | 1.07246101 |
| 109 | MP0001533_abnormal_skeleton_physiology | 1.05391746 |
| 110 | MP0004858_abnormal_nervous_system | 1.04928896 |
| 111 | MP0000955_abnormal_spinal_cord | 1.04801448 |
| 112 | MP0002132_abnormal_respiratory_system | 1.03658103 |
| 113 | MP0001663_abnormal_digestive_system | 1.03437930 |
| 114 | MP0000015_abnormal_ear_pigmentation | 1.03311441 |
| 115 | MP0003329_amyloid_beta_deposits | 1.03219663 |
| 116 | MP0002066_abnormal_motor_capabilities/c | 1.03101309 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 1.02541761 |
| 118 | MP0005310_abnormal_salivary_gland | 1.02351589 |
| 119 | MP0004947_skin_inflammation | 1.02295893 |
| 120 | MP0001440_abnormal_grooming_behavior | 1.02069244 |
| 121 | MP0006276_abnormal_autonomic_nervous | 1.01982437 |
| 122 | MP0000604_amyloidosis | 1.01897422 |
| 123 | MP0002998_abnormal_bone_remodeling | 1.01186902 |
| 124 | MP0009764_decreased_sensitivity_to | 0.99441569 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.99179925 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.98903628 |
| 127 | MP0008469_abnormal_protein_level | 0.98095953 |
| 128 | MP0002139_abnormal_hepatobiliary_system | 0.96895755 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.96047796 |
| 130 | MP0005365_abnormal_bile_salt | 0.94482176 |
| 131 | MP0005085_abnormal_gallbladder_physiolo | 0.93606743 |
| 132 | MP0005377_hearing/vestibular/ear_phenot | 0.93258688 |
| 133 | MP0003878_abnormal_ear_physiology | 0.93258688 |
| 134 | MP0002882_abnormal_neuron_morphology | 0.92962120 |
| 135 | MP0001486_abnormal_startle_reflex | 0.92046571 |
| 136 | MP0009278_abnormal_bone_marrow | 0.92037593 |
| 137 | MP0004130_abnormal_muscle_cell | 0.91035963 |
| 138 | MP0003632_abnormal_nervous_system | 0.90844653 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.90666484 |
| 140 | MP0001968_abnormal_touch/_nociception | 0.89983860 |
| 141 | MP0005448_abnormal_energy_balance | 0.89466005 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.88852670 |
| 143 | MP0003690_abnormal_glial_cell | 0.88843086 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.87133580 |
| 145 | MP0002063_abnormal_learning/memory/cond | 0.87107711 |
| 146 | MP0008995_early_reproductive_senescence | 0.86980735 |
| 147 | MP0008872_abnormal_physiological_respon | 0.86866282 |
| 148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86767934 |
| 149 | MP0005334_abnormal_fat_pad | 0.86621723 |
| 150 | MP0000920_abnormal_myelination | 0.84997647 |
| 151 | MP0002095_abnormal_skin_pigmentation | 0.83888291 |
| 152 | MP0001485_abnormal_pinna_reflex | 0.83087638 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.81962416 |
| 154 | MP0001944_abnormal_pancreas_morphology | 0.81517546 |
| 155 | MP0003075_altered_response_to | 0.80676251 |
| 156 | MP0003698_abnormal_male_reproductive | 0.80053066 |
| 157 | MP0002734_abnormal_mechanical_nocicepti | 0.79424069 |
| 158 | MP0005636_abnormal_mineral_homeostasis | 0.79381796 |
| 159 | MP0002970_abnormal_white_adipose | 0.78615918 |
| 160 | MP0001905_abnormal_dopamine_level | 0.78508799 |
| 161 | MP0001984_abnormal_olfaction | 0.77881936 |
| 162 | MP0003959_abnormal_lean_body | 0.77707464 |
| 163 | MP0005332_abnormal_amino_acid | 0.75079585 |
| 164 | MP0002163_abnormal_gland_morphology | 0.74783772 |
| 165 | MP0008874_decreased_physiological_sensi | 0.74636547 |
| 166 | MP0001963_abnormal_hearing_physiology | 0.74044916 |
| 167 | MP0002184_abnormal_innervation | 0.73675952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of binocular vision (HP:0011514) | 3.99604755 |
| 2 | Diplopia (HP:0000651) | 3.99604755 |
| 3 | Febrile seizures (HP:0002373) | 3.84650391 |
| 4 | Epileptic encephalopathy (HP:0200134) | 3.82820728 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.68226526 |
| 6 | Tubular atrophy (HP:0000092) | 3.57333899 |
| 7 | Spontaneous hematomas (HP:0007420) | 3.56169222 |
| 8 | Genetic anticipation (HP:0003743) | 3.51871834 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.35745463 |
| 10 | Increased circulating renin level (HP:0000848) | 3.25208190 |
| 11 | Papilledema (HP:0001085) | 3.14874824 |
| 12 | Abnormal eating behavior (HP:0100738) | 3.02086855 |
| 13 | Polyphagia (HP:0002591) | 3.00616801 |
| 14 | Abnormality of macrophages (HP:0004311) | 2.98065452 |
| 15 | Focal seizures (HP:0007359) | 2.95665336 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 2.95576259 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 2.91958778 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.90539381 |
| 19 | Recurrent abscess formation (HP:0002722) | 2.83574558 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 2.83092765 |
| 21 | Agitation (HP:0000713) | 2.80493109 |
| 22 | Hyperventilation (HP:0002883) | 2.79131299 |
| 23 | Postural instability (HP:0002172) | 2.76227980 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.75143040 |
| 25 | Disinhibition (HP:0000734) | 2.74827959 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.74453923 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 2.74351746 |
| 28 | Microcytic anemia (HP:0001935) | 2.72682336 |
| 29 | Abnormal platelet function (HP:0011869) | 2.72133860 |
| 30 | Impaired platelet aggregation (HP:0003540) | 2.72133860 |
| 31 | Obstructive sleep apnea (HP:0002870) | 2.71825641 |
| 32 | Focal motor seizures (HP:0011153) | 2.70840103 |
| 33 | EEG with generalized epileptiform discharges (HP:0011198) | 2.67683002 |
| 34 | Mutism (HP:0002300) | 2.66658418 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66233951 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.66233951 |
| 37 | Abnormality of the fingertips (HP:0001211) | 2.66225024 |
| 38 | Large for gestational age (HP:0001520) | 2.66016729 |
| 39 | Macroorchidism (HP:0000053) | 2.65714028 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.65500837 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.64536298 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60504337 |
| 43 | Hemiparesis (HP:0001269) | 2.59495865 |
| 44 | Epistaxis (HP:0000421) | 2.59236552 |
| 45 | Hyperthyroidism (HP:0000836) | 2.58855545 |
| 46 | Chest pain (HP:0100749) | 2.56242715 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.54855600 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.53852365 |
| 49 | Hyperkalemia (HP:0002153) | 2.53698563 |
| 50 | Hypsarrhythmia (HP:0002521) | 2.52686003 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.49954191 |
| 52 | Gingival bleeding (HP:0000225) | 2.49529230 |
| 53 | Abnormality of DNA repair (HP:0003254) | 2.48069767 |
| 54 | Atonic seizures (HP:0010819) | 2.43165074 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.42508298 |
| 56 | Hemiplegia (HP:0002301) | 2.41681328 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36752814 |
| 58 | Ketosis (HP:0001946) | 2.32315775 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.31960677 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29984254 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29984254 |
| 62 | Sleep apnea (HP:0010535) | 2.28664702 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28301765 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28301765 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28301765 |
| 66 | Status epilepticus (HP:0002133) | 2.28250533 |
| 67 | Pustule (HP:0200039) | 2.26288518 |
| 68 | Absence seizures (HP:0002121) | 2.24824066 |
| 69 | Recurrent skin infections (HP:0001581) | 2.24103154 |
| 70 | Nephronophthisis (HP:0000090) | 2.21990343 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.21268280 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21142313 |
| 73 | Vasculitis (HP:0002633) | 2.21006917 |
| 74 | Pulmonary embolism (HP:0002204) | 2.20893013 |
| 75 | Bile duct proliferation (HP:0001408) | 2.19188221 |
| 76 | Abnormal biliary tract physiology (HP:0012439) | 2.19188221 |
| 77 | Impaired smooth pursuit (HP:0007772) | 2.19049789 |
| 78 | Asymmetry of the thorax (HP:0001555) | 2.17710847 |
| 79 | Visual hallucinations (HP:0002367) | 2.17348926 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17167563 |
| 81 | Obstructive lung disease (HP:0006536) | 2.17167563 |
| 82 | Action tremor (HP:0002345) | 2.16356922 |
| 83 | Hemoptysis (HP:0002105) | 2.16007847 |
| 84 | Ankle clonus (HP:0011448) | 2.15672481 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14049768 |
| 86 | Congenital stationary night blindness (HP:0007642) | 2.13932353 |
| 87 | Dialeptic seizures (HP:0011146) | 2.13908174 |
| 88 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.13762213 |
| 89 | Supranuclear gaze palsy (HP:0000605) | 2.12632219 |
| 90 | Absent speech (HP:0001344) | 2.12088781 |
| 91 | Widely spaced teeth (HP:0000687) | 2.11472610 |
| 92 | Recurrent viral infections (HP:0004429) | 2.11226749 |
| 93 | Thrombocytosis (HP:0001894) | 2.11103264 |
| 94 | Abnormality of the renal medulla (HP:0100957) | 2.11067001 |
| 95 | Hypomagnesemia (HP:0002917) | 2.10382895 |
| 96 | Inappropriate behavior (HP:0000719) | 2.10211802 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09810615 |
| 98 | Decreased circulating renin level (HP:0003351) | 2.09149225 |
| 99 | Hematochezia (HP:0002573) | 2.07886114 |
| 100 | Meningitis (HP:0001287) | 2.06763971 |
| 101 | Pancreatic cysts (HP:0001737) | 2.06056514 |
| 102 | Severe visual impairment (HP:0001141) | 2.05848672 |
| 103 | Hepatocellular necrosis (HP:0001404) | 2.03762101 |
| 104 | Polydipsia (HP:0001959) | 2.03591064 |
| 105 | Abnormal drinking behavior (HP:0030082) | 2.03591064 |
| 106 | Broad-based gait (HP:0002136) | 2.01430876 |
| 107 | Ventricular fibrillation (HP:0001663) | 2.00196012 |
| 108 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.99085397 |
| 109 | Cellulitis (HP:0100658) | 1.97727239 |
| 110 | Hypothermia (HP:0002045) | 1.97640725 |
| 111 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.97398737 |
| 112 | Truncal ataxia (HP:0002078) | 1.97227589 |
| 113 | Chronic otitis media (HP:0000389) | 1.96654114 |
| 114 | Abnormal hair whorl (HP:0010721) | 1.96423503 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 1.96355455 |
| 116 | Truncal obesity (HP:0001956) | 1.95471320 |
| 117 | Conjunctival telangiectasia (HP:0000524) | 1.92519696 |
| 118 | Hypoglycemic coma (HP:0001325) | 1.92273043 |
| 119 | Truncus arteriosus (HP:0001660) | 1.92236614 |
| 120 | Spastic gait (HP:0002064) | 1.91684107 |
| 121 | Petechiae (HP:0000967) | 1.91290238 |
| 122 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.90684941 |
| 123 | Agammaglobulinemia (HP:0004432) | 1.90197168 |
| 124 | T lymphocytopenia (HP:0005403) | 1.89863105 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.89690804 |
| 126 | Recurrent bronchitis (HP:0002837) | 1.88313395 |
| 127 | Abnormality of the corticospinal tract (HP:0002492) | 1.87937385 |
| 128 | Myokymia (HP:0002411) | 1.86959292 |
| 129 | Abnormality of renin-angiotensin system (HP:0000847) | 1.86448961 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.86240099 |
| 131 | Large eyes (HP:0001090) | 1.85568812 |
| 132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84591360 |
| 133 | Myocardial infarction (HP:0001658) | 1.83817306 |
| 134 | Autoimmune thrombocytopenia (HP:0001973) | 1.82648902 |
| 135 | Medial flaring of the eyebrow (HP:0010747) | 1.82519991 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 1.81885871 |
| 137 | Increased serum ferritin (HP:0003281) | 1.81689574 |
| 138 | Abnormal EKG (HP:0003115) | 1.81059719 |
| 139 | Abnormality of potassium homeostasis (HP:0011042) | 1.79731579 |
| 140 | Arterial thrombosis (HP:0004420) | 1.78716806 |
| 141 | Abnormality of T cell number (HP:0011839) | 1.78040089 |
| 142 | Chronic hepatic failure (HP:0100626) | 1.77112381 |
| 143 | Thoracic kyphosis (HP:0002942) | 1.76790260 |
| 144 | Attenuation of retinal blood vessels (HP:0007843) | 1.76411304 |
| 145 | Prolonged QT interval (HP:0001657) | 1.75910675 |
| 146 | Colitis (HP:0002583) | 1.75853706 |
| 147 | Episodic fever (HP:0001954) | 1.75379300 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.75046410 |
| 149 | Spastic tetraparesis (HP:0001285) | 1.73778800 |
| 150 | Abnormality of saccadic eye movements (HP:0000570) | 1.73149123 |
| 151 | Spinal canal stenosis (HP:0003416) | 1.72397337 |
| 152 | Metabolic alkalosis (HP:0200114) | 1.72179570 |
| 153 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.71345660 |
| 154 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.71345660 |
| 155 | Ketoacidosis (HP:0001993) | 1.71322418 |
| 156 | Myositis (HP:0100614) | 1.70525197 |
| 157 | Hepatic necrosis (HP:0002605) | 1.70190659 |
| 158 | Urethral obstruction (HP:0000796) | 1.70134066 |
| 159 | Sensorimotor neuropathy (HP:0007141) | 1.69652027 |
| 160 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69598152 |
| 161 | Hypoglycemic seizures (HP:0002173) | 1.69525988 |
| 162 | Hypochromic anemia (HP:0001931) | 1.69375032 |
| 163 | Cutaneous melanoma (HP:0012056) | 1.69163422 |
| 164 | Short nail (HP:0001799) | 1.66751023 |
| 165 | Cerebral hemorrhage (HP:0001342) | 1.66578772 |
| 166 | Progressive cerebellar ataxia (HP:0002073) | 1.66289361 |
| 167 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.66265889 |
| 168 | Polyuria (HP:0000103) | 1.66085435 |
| 169 | Metaphyseal dysplasia (HP:0100255) | 1.66066454 |
| 170 | Bradykinesia (HP:0002067) | 1.65953577 |
| 171 | Aplastic anemia (HP:0001915) | 1.65629397 |
| 172 | Hypochromic microcytic anemia (HP:0004840) | 1.65585268 |
| 173 | Severe combined immunodeficiency (HP:0004430) | 1.65478301 |
| 174 | Volvulus (HP:0002580) | 1.65029599 |
| 175 | Generalized tonic-clonic seizures (HP:0002069) | 1.64753814 |
| 176 | Abnormality of magnesium homeostasis (HP:0004921) | 1.64601069 |
| 177 | Stomatitis (HP:0010280) | 1.64385816 |
| 178 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.63970624 |
| 179 | Hypokalemic alkalosis (HP:0001949) | 1.63886972 |
| 180 | Choreoathetosis (HP:0001266) | 1.62894058 |
| 181 | Tachypnea (HP:0002789) | 1.62191869 |
| 182 | Hypoplastic iliac wings (HP:0002866) | 1.61972502 |
| 183 | Stereotypic behavior (HP:0000733) | 1.60753392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.02141908 |
| 2 | STK16 | 3.33750550 |
| 3 | MAP4K1 | 3.27614708 |
| 4 | PLK4 | 3.11305273 |
| 5 | TXK | 3.03297383 |
| 6 | TGFBR1 | 2.90492065 |
| 7 | FGFR4 | 2.88089273 |
| 8 | TAOK3 | 2.52427829 |
| 9 | DAPK2 | 2.47653823 |
| 10 | TGFBR2 | 2.41583199 |
| 11 | MAP2K7 | 2.35560136 |
| 12 | FGFR2 | 2.33473340 |
| 13 | NTRK2 | 2.10896915 |
| 14 | SCYL2 | 2.08427266 |
| 15 | JAK3 | 2.08098792 |
| 16 | MAP3K14 | 1.99810925 |
| 17 | TNK2 | 1.94946403 |
| 18 | MARK1 | 1.93395143 |
| 19 | PAK6 | 1.91346551 |
| 20 | KSR2 | 1.85668501 |
| 21 | EEF2K | 1.81011326 |
| 22 | SIK2 | 1.75438296 |
| 23 | FGFR3 | 1.74052409 |
| 24 | WNK4 | 1.63125144 |
| 25 | MAP3K13 | 1.56295855 |
| 26 | KIT | 1.49859669 |
| 27 | HIPK2 | 1.44968741 |
| 28 | ZAP70 | 1.42692369 |
| 29 | RIPK4 | 1.42662089 |
| 30 | MAPK12 | 1.40626550 |
| 31 | MAP2K6 | 1.39990788 |
| 32 | UHMK1 | 1.39262541 |
| 33 | ITK | 1.37391335 |
| 34 | PRPF4B | 1.35856080 |
| 35 | PASK | 1.34826056 |
| 36 | TRIB3 | 1.33929538 |
| 37 | IRAK4 | 1.32848208 |
| 38 | WNK1 | 1.32585176 |
| 39 | CAMKK2 | 1.32418799 |
| 40 | CAMK1 | 1.26949319 |
| 41 | SYK | 1.25681303 |
| 42 | EPHA4 | 1.24962267 |
| 43 | TEC | 1.21543808 |
| 44 | RET | 1.19913548 |
| 45 | TYRO3 | 1.16373419 |
| 46 | BMPR1B | 1.14708691 |
| 47 | CASK | 1.13488858 |
| 48 | BRD4 | 1.10256777 |
| 49 | SGK223 | 1.09126479 |
| 50 | SGK494 | 1.09126479 |
| 51 | TAOK1 | 1.08313854 |
| 52 | CDK3 | 1.07968879 |
| 53 | PRKD3 | 1.06670107 |
| 54 | PLK2 | 1.05601085 |
| 55 | SGK1 | 1.04712395 |
| 56 | PAK3 | 1.01491066 |
| 57 | PINK1 | 1.00132404 |
| 58 | RAF1 | 0.98242452 |
| 59 | SGK2 | 0.97343911 |
| 60 | CSNK1A1L | 0.97129879 |
| 61 | MAP4K2 | 0.95747309 |
| 62 | PDPK1 | 0.95504300 |
| 63 | CDK8 | 0.90491321 |
| 64 | ICK | 0.89813812 |
| 65 | INSRR | 0.89809908 |
| 66 | TBK1 | 0.89770980 |
| 67 | IRAK3 | 0.89452976 |
| 68 | CAMK1G | 0.88287275 |
| 69 | NTRK3 | 0.87957489 |
| 70 | HCK | 0.87515830 |
| 71 | PDGFRA | 0.85867437 |
| 72 | FES | 0.85773987 |
| 73 | PTK6 | 0.85065774 |
| 74 | STK38 | 0.84589067 |
| 75 | PKN2 | 0.83512658 |
| 76 | MAP3K7 | 0.82789168 |
| 77 | RPS6KA2 | 0.82310643 |
| 78 | STK11 | 0.82177989 |
| 79 | MAPK11 | 0.81805538 |
| 80 | NME2 | 0.81650698 |
| 81 | ALK | 0.79663826 |
| 82 | STK10 | 0.78915329 |
| 83 | MAPK7 | 0.78540366 |
| 84 | TYK2 | 0.78082088 |
| 85 | MAP3K1 | 0.77620601 |
| 86 | BTK | 0.76078290 |
| 87 | MAP3K9 | 0.75927741 |
| 88 | JAK2 | 0.75637576 |
| 89 | PRKD2 | 0.74357161 |
| 90 | CSNK1G3 | 0.74208026 |
| 91 | BLK | 0.73822559 |
| 92 | CSNK1G2 | 0.73262009 |
| 93 | CDK5 | 0.72678323 |
| 94 | PIK3CA | 0.72360662 |
| 95 | IRAK2 | 0.71784937 |
| 96 | LRRK2 | 0.71528281 |
| 97 | PRKCG | 0.70600584 |
| 98 | IKBKE | 0.69223999 |
| 99 | PRKAA2 | 0.68887874 |
| 100 | AKT3 | 0.68818045 |
| 101 | LCK | 0.68065857 |
| 102 | PRKAA1 | 0.67562804 |
| 103 | PRKCQ | 0.67453048 |
| 104 | JAK1 | 0.67173184 |
| 105 | GRK6 | 0.67140794 |
| 106 | MAP3K4 | 0.66490025 |
| 107 | PRKCH | 0.66304848 |
| 108 | PRKCZ | 0.66052546 |
| 109 | CAMKK1 | 0.65805773 |
| 110 | LYN | 0.63103017 |
| 111 | PHKG1 | 0.62381771 |
| 112 | PHKG2 | 0.62381771 |
| 113 | TRPM7 | 0.61689179 |
| 114 | TAOK2 | 0.60959653 |
| 115 | CDK9 | 0.60020240 |
| 116 | PDGFRB | 0.59544783 |
| 117 | ERBB3 | 0.59247297 |
| 118 | PTK2B | 0.59123647 |
| 119 | CSNK1G1 | 0.57694601 |
| 120 | CLK1 | 0.56091976 |
| 121 | SIK3 | 0.56086214 |
| 122 | ERN1 | 0.55702526 |
| 123 | CAMK4 | 0.55584339 |
| 124 | SIK1 | 0.54052014 |
| 125 | MAP3K2 | 0.53653673 |
| 126 | NLK | 0.52493270 |
| 127 | CDC42BPA | 0.52198558 |
| 128 | MAPK15 | 0.49288505 |
| 129 | YES1 | 0.48869837 |
| 130 | DYRK1A | 0.48478018 |
| 131 | SGK3 | 0.45342547 |
| 132 | ADRBK2 | 0.44792913 |
| 133 | PDK1 | 0.44075121 |
| 134 | CSK | 0.43227305 |
| 135 | IKBKB | 0.43184541 |
| 136 | KSR1 | 0.42731669 |
| 137 | MARK3 | 0.42483312 |
| 138 | RPS6KA3 | 0.41673843 |
| 139 | CHUK | 0.40864762 |
| 140 | FRK | 0.40421380 |
| 141 | MARK2 | 0.40165756 |
| 142 | RPS6KA4 | 0.39790000 |
| 143 | PKN1 | 0.37223917 |
| 144 | ACVR1B | 0.36273671 |
| 145 | MINK1 | 0.36222054 |
| 146 | MATK | 0.35059522 |
| 147 | MAP2K4 | 0.34814211 |
| 148 | PIK3CG | 0.30345951 |
| 149 | CAMK1D | 0.28853961 |
| 150 | MAPK13 | 0.28013549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.08769177 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.50117059 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42537621 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.04282962 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.03706974 |
| 6 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.95663694 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93897983 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91686143 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90288171 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80480453 |
| 11 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.77259361 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76665614 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70212922 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.69053852 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.67779374 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.67432213 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61240527 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.60169232 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58625098 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53731125 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50641877 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46318959 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.44555735 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.42738388 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.41625579 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39668276 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39493201 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38930723 |
| 29 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.38050479 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.37748978 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.36456356 |
| 32 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.35890709 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.32411279 |
| 34 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.30739955 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30249328 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29000253 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28168448 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.27874826 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25811217 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24889959 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.22612801 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21959385 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21476155 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19759390 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19267609 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18593836 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17620052 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17445701 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16617352 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16500465 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15996605 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15957610 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14229491 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11440467 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.11015071 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10571970 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10396171 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09674166 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09017304 |
| 60 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07643358 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07462983 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07334269 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.06812633 |
| 64 | * Insulin resistance_Homo sapiens_hsa04931 | 1.06536388 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 1.05317434 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 1.03276555 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03180023 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02765326 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00349148 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.99091994 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.97573560 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96873871 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96582930 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95127409 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94856781 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.93094172 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93080988 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90819106 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90232632 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87859668 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83551231 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83180555 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.82880540 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81255869 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.79702388 |
| 86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79314797 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79103988 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.78935081 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78335051 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77756146 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.74966731 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74177892 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74113384 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73678248 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73482011 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72704233 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.71035661 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70105585 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69581136 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.69570375 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68133744 |
| 102 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66995163 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66805628 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66688487 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66365166 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66184319 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65506809 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65195723 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65127464 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64818531 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.64555788 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.64385285 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64138756 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63896874 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63097602 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.61513380 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60732154 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60450057 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60044218 |
| 120 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59990886 |
| 121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59362066 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59173423 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59171927 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58928905 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58859614 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.57872173 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57549145 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56885683 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56374598 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.56132512 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55650790 |
| 132 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53742496 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53235307 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52256124 |
| 135 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52176992 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51907932 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50929960 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49985887 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49978236 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49773859 |
| 141 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49450935 |
| 142 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49325436 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.47544375 |
| 144 | Gap junction_Homo sapiens_hsa04540 | 0.46374219 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45302313 |

